Introduction
Since its discovery in 1770 by Scheele and Priestley, oxygen has become one of the most effective, widely available, and cheap therapeutic agents available. In a wide range of hypoxic and/or hypoxemic disorders, normobaric hyperoxia can improve tissue oxygenation and thus, frequently provides life-saving benefits. Furthermore, hyperoxic ventilation can diminish the risk of surgical wound infections following colorectal resection 1, 2 and reduce ischemic brain damage in experimental stroke 3 . However, exposure to increased oxygen concentrations for hours or days results in deleterious effects on lung function in humans 4 and ultimately in death from hyperoxic lung injury in laboratory animals 5 . The morphological changes in hyperoxic lung injury share many common features with other forms of acute lung injury in that an initial exudative phase, characterized by inflammation, atelectasis, and edema formation, is followed by a fibroproliferative phase with irreversible loss of respiratory function 6 . Sequestration and infiltration of circulating neutrophils and platelets are early hallmarks of the inflammatory phase and indicate the activation of pulmonary microvascular endothelial cells by hyperoxia 7 . Early changes in endothelial cell ultrastructure 8 and increased microvascular leakage 9 identify lung endothelial cells as a primary target in hyperoxic stress. The length of the initiation phase preceding changes in global lung function and morphology varies inversely with the concentration of oxygen 7 , and has been reported to range between 14 h and 30 h at O 2 concentrations of 70 % or higher in healthy human subjects 4, 10 . Shorter episodes of normobaric hyperoxia are therefore generally considered as clinically safe. In contrast, in vitro data suggest that lung endothelial cells respond to hyperoxia within 30 to 60 min 11, 12 , and biochemical alterations may occur within seconds. Hence, endothelial cell activation and/or damage may significantly precede overt 4 morphologic and/or functional changes, and could initiate long-term effects on lung structure and function.
The pathogenesis of hyperoxic lung injury has been attributed to the generation of reactive oxygen species (ROS), including superoxide (O 2 -•), hydrogen peroxide (H 2 O 2 ), and hydroxyl radical (HO•), and subsequent formation of potent oxidants such as peroxynitrite (ONOO -) 13 . These highly reactive intermediates do not only cause cellular and subcellular damage by initiating oxidative and peroxidative chain reactions, but, in addition, serve as intracellular signaling molecules to elicit active cell responses. Superoxide, in particular, seems to play a predominant pathophysiological role in hyperoxic lung injury. Overexpression of any of the three mammalian isoenzymes of superoxide dismutase (SOD), which rapidly catalyze the dismutation of O 2 - • to H 2 O 2 , provides partial or complete protection from hyperoxic lung injury 14, 15, 16 . In contrast, mice lacking extracellular SOD are more sensitive to hyperoxia with an earlier onset of edema and reduced survival 17 .
A variety of mechanisms have been proposed to contribute to enhanced superoxide production during hyperoxia. In lung homogenates and slices exposed to 100% O 2 , Crapo and coworkers detected an increased electron leak from the mitochondrial respiratory chain which results in superoxide production 18 . In contrast, Parinandi and coworkers recently reported hyperoxia-induced ROS generation in cultured human pulmonary artery endothelial cells by NAD(P)H oxidase 11 .
Although this enzyme was long considered to be a unique feature of phagocytes by which they can rapidly generate vast amounts of O 2 - • in order to kill invading pathogens, recent studies also demonstrate its expression in endothelial and vascular smooth muscle cells 19 . In these non- In the intact pulmonary microcirculation, the onset of endothelial responses to hyperoxia and underlying cellular mechanisms are yet unclear. A traditional difficulty in this understanding lies in the dynamic quantification of ROS formation in intact lungs during normobaric hyperoxia. Using our recently developed in situ fluorescence imaging techniques 21 , we determined endothelial ROS formation during normobaric hyperoxia and underlying cellular signaling pathways in the isolated blood-perfused rat lung. 6 
Materials and Methods
Animals. Male Sprague-Dawley rats (423 ± 17 g bw) were obtained from the local breeding facility of the academical institution. All animals received care in accordance with the "Guide for the Care and Use of Laboratory Animals" (NIH publication no. 86-23, rev. 1985) . The study was approved by the animal care and use committees of the local government authorities. , and 20 HEPES (Serva, Heidelberg, Germany) at pH 7.4 and osmolarity of 295 mosM. 7 Lung preparation. Experimental procedures have previously been described 21, 22 . In brief, lungs excised from anesthetized Sprague-Dawley rats were continuously pump-perfused with 14 mL/min autologous heparinized (500 U) rat blood at 37°C. At baseline, lungs were constantly inflated with a gas mixture of 21% O 2 , 5% CO 2 , balance N 2 at a positive airway pressure of 5 cmH 2 O. Left atrial pressure (P LA ) was adjusted to 3 cmH 2 O, yielding pulmonary artery pressures (P PA ) of 10±1 cmH 2 O. P PA and P LA were continuously monitored and recorded (Recomed; Hellige, Freiburg, Germany). Lungs were positioned on a custom-built microscope stage and superfused with normal saline at 37°C to prevent drying. For local delivery of fluorescent probes and drugs to pulmonary microvessels in situ, a microcatheter (Ref. 800/110/100; SIMS Portex Ltd., Kent, UK) was advanced through the left atrium and wedged in a pulmonary vein draining a small capillary area on the lung surface.
In situ fluorescence microscopy. Fluorophores loaded to rat lung capillary endothelial cells were visualized on an Olympus BX50 upright microscope (Olympus, Hamburg, Germany). Light from a 75-watt xenon source was narrowed to a near monochromatic beam by a digitally controled galvanometric scanner (Polychrome II; TILL Photonics, Martinsried, Germany). Fluorescence emission was collected through an apochromat objective (UAPO 40x W2/340; Olympus) and appropriate dichroic and emission filters (FT 425 and BP 505-530, or DCLP 500 and LP 515) by a CCD camera (Sensicam; PCO, Kelheim, Germany) and subjected to digital image analysis (TILLvisION 4.0; TILL Photonics). Single venular capillaries were viewed at a focal plane corresponding to maximum vessel diameter (17-25 µm). 8 Capillary imaging and analysis. Intracellular ROS concentrations in endothelial cells were measured in situ using two intracellular fluorescent probes, H 2 DCF-DA and hydroethidine.
H 2 DCF-DA (2 µmol/L) was continuously infused into lung capillaries via the venous microcatheter, as previously described 23 . Image acquisition was started 30 min after the onset of fluorophore infusion. Capillaries were excited at 488 nm and emission > 515 nm was recorded. HE (20 Smol/L) was loaded to lung endothelial cells in situ for 30 min and fluorescence of hydroethidine and its oxidation products ethidium (E + ) and hydroxyethidium (2-OH-E + ), respectively, were measured at excitation/emission wavelengths of 360 nm/425 nm and 470 nm/ > 515 nm according to the respective spectra 24, 25 . Our fura 2 ratio imaging technique for the quantification of intracellular calcium concentrations ([Ca 2+ ] i ) in endothelial cells of lung venular capillaries has been described previously 22 . In brief, membrane-permeant fura 2-AM (5 µmol/L), which deesterifies intracellularly to impermeant fura 2, was infused into lung capillaries for 20 min 
Results
For in situ determination of endothelial ROS production, lung venular capillaries were continuously infused with membrane permeant H 2 DCF-DA, which de-esterifies intracellularly to H 2 DCF, the substrate that is oxidized to fluorescent DCF by ROS. Images of subpleural venular capillaries revealed DCF fluorescence in the capillary wall, but not in the pericapillary space (Fig.   1A) . The fluorescent cells always stained positive for the endothelial marker Alexa Fluor 488 AcLDL, confirming their endothelial phenotype (n=4). Under physiological conditions, the oxidation of H 2 DCF to DCF is irreversible. Due to the rapid leakage of the dye from endothelial cells 27 , continuous capillary infusion of H 2 DCF-DA can establish a steady state of dye delivery and removal which allows for near-online monitoring of endothelial ROS production 28, 29 . Accordingly, endothelial fluorescence was stable during continuous dye infusion, but decreased reversibly to background levels upon discontinuation of dye delivery (Fig. 1B) . Capillary infusion of a single bolus of H 2 O 2 rapidly increased endothelial DCF fluorescence, which returned to background levels within minutes after washout of the bolus ( returned to rates similar to baseline within 20 min after return to normoxia (Fig. 3G) . In normoxic controls, fluorescence of HE and its oxidation products changed linearly at baseline rates over the observation period.
Next, we investigated mechanisms underlying endothelial ROS formation in hyperoxia by inhibiting potentially involved cellular pathways. The mitochondrial inhibitor rotenone which blocks electron transport at complex I significantly reduced baseline DCF fluorescence and completely blocked the hyperoxia-induced fluorescence increase (Fig. 4A ). These findings suggest that baseline ROS levels and hyperoxia-induced ROS were at least in part of mitochondrial origin.
Attenuation of the fluorescence increase was also achieved by DPI (Fig. 4B ), an inhibitor of flavoprotein oxidoreductases which blocks NAD(P)H oxidases, nitric oxide synthases, and xanthine oxidase. Although DPI may also block mitochondrial complex I and thus reduce 31 or even increase 32 mitochondrial superoxide production, it does not seem to interfere with mitochondrial electron transport in situ at the given concentrations 28 . In accordance with this notion and unlike rotenone, DPI did not reduce baseline DCF fluorescence in lung capillaries. The fluorescence response to hyperoxia was also attenuated by AEBSF (Fig. 4C ), a serine protease inhibitor which interferes with the assembly of the multicomponental NAD(P)H oxidase complex 26 . In contrast, inhibition of endothelial nitric oxide synthase (eNOS), which is also sensitive to DPI, by L-NAME had no effect, demonstrating that eNOS products were not involved 14 in the fluorescence response (n=5, data not shown). The effects of DPI and AEBSF were virtually identical, in that both inhibitors did not prevent the intitial increase of DCF fluorescence during the first 30 min of the hyperoxic interval, but significantly attenuated the subsequent progressive increase in fluorescence. This similarity suggests an involvement of NAD(P)H oxidase which seems to contribute in particular to progressive ROS production after more than 30 min of hyperoxia.
Endothelial cells express the NAD(P)H oxidase isoform Nox2 (gp91 (Fig. 5E,F) , indicating absence of Rac1 preassembly with the membrane-bound NAD(P)H oxidase subunits. Taken together, these findings suggest that, in addition to mitochondrial electron transport, Rac1-dependent activation of NAD(P)H oxidase contributed to hyperoxia-induced ROS production in lung capillary endothelial cells. The fact that the portion of ROS production which was inhibitable by DPI and AEBSF, respectively, was also completely blocked by rotenone suggests that NAD(P)H oxidase activation occurred downstream of mitochondrial ROS production. Consistent with this notion, hyperoxia-induced immunofluorescence of translocated Rac1 was reduced to normoxic baseline levels in the presence of rotenone (Fig. 5G) 36, 37 . By use of the fura 2 ratio imaging technique, we determined that hyperoxia induced a rise in mean endothelial [Ca 2+ ] i in lung capillaries (Fig. 6A) . This response increased with the duration of hyperoxic ventilation and was associated with a concomittant increase in the amplitude of endothelial [Ca 2+ ] i oscillations, while oscillation frequency did not change from baseline ( ] i increase (Fig. 7D) . The analogy of this inhibition pattern with the effects of DPI and AEBSF on ROS production is consistent with the ] i , Rac1, and NAD(P)H oxidase and results in progressive ROS generation. 19 
Methodological considerations
To establish normoxic and hyperoxic conditions, isolated perfused lungs were ventilated with 21% O 2 or 70% O 2 , respectively. Between periods of image acquisition, cyclic lung ventilation was required to establish stable hyperoxic conditions. Yet, cyclic ventilation itself did not contribute to endothelial ROS generation or [Ca 2+ ] i signaling as confirmed in normoxic control experiments. For the same reason, effects of heparin, which was used as anticoagulant, can be excluded as mechanism underlying the detected endothelial responses. Since P CO 2 and pH were constant throughout experiments, differences between hyperoxic and normoxic ventilation can be directly attributed to differences in P O 2 .
While endothelial [Ca 2+ ] i signaling was measured using our previously described fura 2 ratio imaging technique . Recently it was reported that HE may also react with superoxide to form fluorescent 2-hydroxyethidium (2-OH-E + ) which exhibits a left-shifted emission spectrum as compared to E + upon excitation with blue light 25, 41 . Therefore, a long-pass emission filter with a low cut-off was applied to allow for detection of both fluorescent products.
ROS production by the mitochondrial electron transport chain
Hyperoxic ventilation for 90 min increased endothelial DCF fluorescence significantly yet reversibly, demonstrating that a rather short hyperoxic interval suffices to induce active cellular responses in lung capillaries. Since the fluorescence increase was conserved during buffer perfusion, i.e. in the absence of circulating blood cells, ROS production occured in the alveolocapillary wall. ROS generation in less than 90 min was confirmed by a marked decrease in HE fluorescence and a mirror-image increase in the combined fluorescence of its oxidation products, This notion of a physiological "electron leak" is consistent with basal ROS production in lung endothelial cells reflected by a slow rate of HE oxidation at baseline 24 . This basal ROS production was largely derived from mitochondria, since inhibition of electron transport at complex I by rotenone reduced baseline DCF fluorescence by more than 50 %.
Hyperoxic ventilation increased superoxide formation by the respiratory chain, which was equivalent to the fraction of DCF fluorescence that was insensitive to the NAD(P)H oxidase inhibitors DPI or AEBSF, but blocked by rotenone. This DPI-insensitive fluorescence was constant throughout the hyperoxic interval, yet rapidly dropped to baseline values upon return to normoxia. This pattern is characteristic for a stoichiometric effect of oxygen tension on superoxide production by the respiratory chain, which is primarily controlled by mass action 43 . Oxygen-dependent superoxide production from the electron transport chain has previously been detected in vitro in rat lung slices and isolated mitochondria 18 , in cultured sheep pulmonary microvascular endothelial cells 12 , and in submitochondrial membranes 44 . Yet to our knowledge, this is the first evidence demonstrating hyperoxia-induced mitochondrial ROS production in endothelial cells of intact lung microvessels in situ. 22 
Endothelial calcium signaling
Although the mitochondrial respiratory chain was the predominant initial source of ROS and its inhibition by rotenone blocked all subsequent cellular events, additional enzymatic sources sensitive to DPI and AEBSF contributed to hyperoxia-induced ROS formation. Activation of these mechanisms depended critically on mitochondrial ROS and endothelial [ 34 . By immunofluorescence assay, we show that hyperoxia induced membrane translocation of Rac1 which was blocked by BAPTA and hence, was Ca 2+ -dependent.
Activation of NAD(P)H-Oxidase
In endothelial cells, GTP-binding and translocation of Rac1 can activate NAD(P)H oxidase and thus, stimulate ROS production. Overexpression of a dominant negative form of Rac1 abrogates 
Clinical significance
The clinical relevance of our findings relates to the controversial question whether hyperoxic intervals of only a few hours may result in or contribute to deleterious lung vascular effects.
Whereas increased generation of ROS is evident in lung endothelial cells in vitro within 30 to 60 min of hyperoxia 11, 12 , clinical use of normobaric hyperoxia for several hours is frequently 25 considered harmless or even recommended, e.g. in order to reduce the risk of post-surgical wound infections 1, 2 . In humans, the first respiratory symptoms have been reported after 6 h oxygen exposure 57 and ultrastructural alterations such as endothelial cell swelling are evident within 14 h at 70 % O 2 10 . In rats, animals die within 60 -72 h of exposure to 100% O 2 , whereas an Fi O 2 of 0.85 is sublethal but may cause platelet accumulation within 3 days and increase lung weight within 5 days of exposure 5, 7 . In isolated perfused rat lungs, confocal microscopy revealed microvascular expression of the adhesion molecule ICAM-1 and leukocyte sequestration in lung capillaries after 48 hours exposure to 90% O 2
58
. Platelets and leukocytes may in fact accumulate even earlier in hyperoxia, since the reported data were measured at the first investigated time points in these studies. The onset of underlying cellular responses can be expected to further precede these pro-inflammatory effects, but had so far not been characterized in vivo or in situ yet.
The severity of hyperoxic lung injury is both time and dose dependent 
